| Year |
Citation |
Score |
| 2022 |
Nimmo C, Millard J, Faulkner V, Monteserin J, Pugh H, Johnson EO. Evolution of drug resistance in the genomic era. Frontiers in Cellular and Infection Microbiology. 12: 954074. PMID 36275027 DOI: 10.3389/fcimb.2022.954074 |
0.271 |
|
| 2021 |
Johnson EO, Hung DT. Using Proteolytic Hypomorphs to Detect Small Molecule Mechanism of Action. Methods in Molecular Biology (Clifton, N.J.). 2314: 323-342. PMID 34235661 DOI: 10.1007/978-1-0716-1460-0_15 |
0.549 |
|
| 2019 |
Johnson EO, Office E, Kawate T, Orzechowski M, Hung DT. A large-scale chemical-genetic strategy enables design of antimicrobial combination chemotherapy in . Acs Infectious Diseases. PMID 31721551 DOI: 10.1021/Acsinfecdis.9B00373 |
0.579 |
|
| 2019 |
Johnson EO, Hung DT. A point of inflection and reflection on systems chemical biology. Acs Chemical Biology. PMID 31613592 DOI: 10.1021/Acschembio.9B00714 |
0.559 |
|
| 2019 |
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N, Delano K, Da Silva I, Davis J, Gallo C, Gardner M, et al. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature. PMID 31217586 DOI: 10.1038/S41586-019-1315-Z |
0.575 |
|
| 2016 |
Johnson EO, Wong LL. Partial fusion of a cytochrome P450 system by carboxy-terminal attachment of putidaredoxin reductase to P450cam (CYP101A1). Catalysis Science & Technology. 6: 7549-7560. PMID 28944003 DOI: 10.1039/C6Cy01042C |
0.622 |
|
| 2012 |
Bell SG, McMillan JH, Yorke JA, Kavanagh E, Johnson EO, Wong LL. Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity. Chemical Communications (Cambridge, England). 48: 11692-4. PMID 23104016 DOI: 10.1039/C2Cc35968E |
0.664 |
|
| 2012 |
Boehringer J, Riedinger C, Paraskevopoulos K, Johnson EO, Lowe ED, Khoudian C, Smith D, Noble ME, Gordon C, Endicott JA. Structural and functional characterization of Rpn12 identifies residues required for Rpn10 proteasome incorporation. The Biochemical Journal. 448: 55-65. PMID 22906049 DOI: 10.1042/BJ20120542 |
0.337 |
|
| 2012 |
Bell SG, Yang W, Tan AB, Zhou R, Johnson EO, Zhang A, Zhou W, Rao Z, Wong LL. The crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding site. Dalton Transactions (Cambridge, England : 2003). 41: 8703-14. PMID 22695988 DOI: 10.1039/C2Dt30783A |
0.661 |
|
| 2010 |
Bell SG, Tan AB, Johnson EO, Wong LL. Selective oxidative demethylation of veratric acid to vanillic acid by CYP199A4 from Rhodopseudomonas palustris HaA2. Molecular Biosystems. 6: 206-14. PMID 20024082 DOI: 10.1039/B913487E |
0.662 |
|
| 2010 |
Bell SG, Xu F, Johnson EO, Forward IM, Bartlam M, Rao Z, Wong LL. Protein recognition in ferredoxin-P450 electron transfer in the class I CYP199A2 system from Rhodopseudomonas palustris. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 15: 315-28. PMID 19904564 DOI: 10.1007/S00775-009-0604-7 |
0.671 |
|
| 2009 |
Xu F, Bell SG, Peng Y, Johnson EO, Bartlam M, Rao Z, Wong LL. Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris. Proteins. 77: 867-80. PMID 19626710 DOI: 10.1002/Prot.22510 |
0.658 |
|
| 2009 |
Xu F, Bell SG, Peng Y, Johnson EO, Bartlam M, Rao Z, Wong L. Correction to the article “Crystal Structure of a Ferredoxin Reductase for the CYP199A2 System from Rhodopseudomonas palustris
” Proteins: Structure, Function, and Bioinformatics. 78: 501-501. DOI: 10.1002/Prot.22627 |
0.597 |
|
| Show low-probability matches. |